Oncotalks hematology videos and news

Albania

ESMO 2019 Valentina Guarneri, MD, PhD; Overall survival (OS) results of the Phase III MONALEESA-3 trial

ESMO 2019 Valentina Guarneri, MD, PhD; Overall survival (OS) results of the Phase III MONALEESA-3 trial

Valentina Guarneri, MD, PhD from the University of Padua, Padua, Italy is commenting on the abstract: LBA7_PR - Overall survival (OS) results of the Phase III MONALEESA-3 trial of postmenopausal patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor 2-negative (HER2−) advanced breast cancer (ABC) treated with fulvestrant (FUL) ± ribociclib (RIB)
ESMO , Kisqali Channel , Latvia , Lithuania , Estonia , Hungary , Albania
00:03:29
ESMO 2019 Ivan Bilić, MD, PhD'; Overall survival (OS) results of the Phase III MONALEESA-3 trial

ESMO 2019 Ivan Bilić, MD, PhD'; Overall survival (OS) results of the Phase III MONALEESA-3 trial

Ivan Bilić, MD, PhD from the University Hospital Centre Zagreb, Croatia is commenting on the abstract: LBA7_PR - Overall survival (OS) results of the Phase III MONALEESA-3 trial of postmenopausal patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor 2-negative (HER2−) advanced breast cancer (ABC) treated with fulvestrant (FUL) ± ribociclib (RIB)
ESMO , Lithuania , Albania
00:06:08
ESMO 2019 Elżbieta Senkus-Konefka, MD, PhD; Overall survival (OS) results of the Phase III MONALEESA-3 trial

ESMO 2019 Elżbieta Senkus-Konefka, MD, PhD; Overall survival (OS) results of the Phase III MONALEESA-3 trial

Elżbieta Senkus-Konefka, MD, PhD from the Medical University of Gdansk, Poland is commenting on the abstract LBA7_PR - Overall survival (OS) results of the Phase III MONALEESA-3 trial of postmenopausal patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor 2-negative (HER2−) advanced breast cancer (ABC) treated with fulvestrant (FUL) ± ribociclib (RIB)Video in Polish
ESMO , Lithuania , Albania
00:03:59
ESMO 2019 prof. Sherko Kümmel, MD; LBA7_PR - Overall survival (OS) results of the Phase III MONALEESA-3 trial

ESMO 2019 prof. Sherko Kümmel, MD; LBA7_PR - Overall survival (OS) results of the Phase III MONALEESA-3 trial

prof. Sherko Kümmel, MD from the Kliniken Essen-Mitte, Essen, Germany is commenting on the abstract LBA7_PR - Overall survival (OS) results of the Phase III MONALEESA-3 trial of postmenopausal patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor 2-negative (HER2−) advanced breast cancer (ABC) treated with fulvestrant (FUL) ± ribociclib (RIB)
ESMO , Hungary , Lithuania , Albania , Slovenia
00:02:45
ESMO 2019 Noam Falbel Pondé, MD, PhD; A Study on the efficacy and safety of Ribociclib in combination with letrozole in Older women (≥70 years)....

ESMO 2019 Noam Falbel Pondé, MD, PhD; A Study on the efficacy and safety of Ribociclib in combination with letrozole in Older women (≥70 years)....

Noam Falbel Pondé, MD, PhD from the A.C.Camargo Cancer Center, São Paulo, Brazil is commenting on the abstract 385TiP - RIBOB : A Study on the efficacy and safety of Ribociclib in combination with letrozole in Older women (≥70 years) with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced Breast cancer (aBC) with no prior systemic therapy for advanced disease
ESMO , Kisqali Channel , Lithuania , Albania
00:05:06
ESMO 2019 Prof. Nagi S. El Saghir, MD; Ribociclib plus Goserelin with hormonal therapy versus physician choice chemotherapy in premenopausal or perimenopausal patients ...

ESMO 2019 Prof. Nagi S. El Saghir, MD; Ribociclib plus Goserelin with hormonal therapy versus physician choice chemotherapy in premenopausal or perimenopausal patients ...

Prof. Nagi S. El Saghir, MD from the American University of Beirut Medical Center, Beirut, Lebanon is commenting on the abstract 386TiP - Ribociclib plus Goserelin with hormonal therapy versus physician choice chemotherapy in premenopausal or perimenopausal patients with HR+, HER2-inoperable locally advanced or metastatic breast cancer - RIGHT Choice study
ESMO , Kisqali Channel , Lithuania , Albania
00:05:31

This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies . If you require further information and/or do not wish to have cookies placed when using the site, visit Privacy Notice.

On acceptance: use all cookie settings
On denial: use only necessary cookies